INDICATIONS     CONTRA-INDICATIONS     DOSAGE     SIDE-EFFECTS     PREGNANCY     OVERDOSE     IDENTIFICATION     PATIENT INFORMATION

Logo PERILAX TABLETS

SCHEDULING STATUS:
Not Scheduled

PROPRIETARY NAME
(and dosage form):

PERILAX TABLETS

COMPOSITION:
Each tablet contains:
Bisacodyl 5,0 mg

PHARMACOLOGICAL CLASSIFICATION:
A 11.5 Medicines acting on the gastro-intestinal tract: Laxatives.

PHARMACOLOGICAL ACTION:
Promotes bowel movement by one or more direct actions on the intestine.

INDICATIONS:
Perilax is indicated for the treatment of occasional constipation, for use as bowel cleansing regimen, preparing the patient for surgery or for preparing the colon for x-ray or endoscopic examination.

CONTRA-INDICATIONS:
Hypersensitivity to the ingredients.
Intestinal obstruction or with undiagnosed abdominal symptoms.

WARNINGS:
This medicine should not be used in the presence of abdominal pain, nausea or vomiting.
Frequent or prolonged use of Perilax may result in dependence on laxatives and loss of normal bowel function. If you have noticed a sudden change in bowel habits that has persisted for a period of greater than 2 weeks, consult a doctor before using the laxative.
The use of any laxative beyond 1 week is not recommended except on the advice of a doctor.
Rectal bleeding or failure to have a bowel movement after use of a laxative may indicate a serious condition. Discontinue use and consult a doctor.
Do not use this product for bowel cleansing unless directed by a doctor.

DOSAGE AND DIRECTIONS FOR USE:
This product generally produces bowel movement in 6 to 12 hours.
Do not chew the tablets
Do not give to children under 6 years of age or to persons who cannot swallow without chewing unless directed by a doctor.
Do not take this product within one hour after taking an antacid or milk.
Adults and children 12 years and over: One to three tablets in a single daily dose.
Children 6 to under 12 years: One tablet in a single daily dose.
Dosage for bowel cleansing (Adults): 2 - 4 tablets the previous night.
Not recommended for use in children under the age of 6 years.

SIDE-EFFECTS AND SPECIAL PRECAUTIONS:
May cause abdominal discomfort, diarrhoea, colic, cramps. Prolonged use may lead to diarrhoea with excessive loss of water and electrolytes and possible atonic non-functioning colon.
Care should be taken in patients with inflammatory bowel disease.

KNOWN SYMPTOMS OF OVERDOSAGE AND PARTICULARS OF ITS TREATMENT:
See “Side-effects and Special Precautions”. Treatment is symptomatic and supportive.

IDENTIFICATION:
Red sugar coated tablet.

PRESENTATION:
Packs of 30 and 200 tablets in securitainers.

STORAGE INSTRUCTIONS:
Store below 25°C.
Protect from light.
KEEP OUT OF REACH OF CHILDREN.

REGISTRATION NUMBER:
E/11.5/1558

NAME AND BUSINESS ADDRESS OF APPLICANT:
Pharmacare Limited
7 Fairclough Road
Port Elizabeth
6001

DATE OF PUBLICATION OF THIS PACKAGE INSERT:
25 July 1997

        D054

New addition to this site: April 2005
Source: Hospital Pharmacy

SAEPI HOME PAGE      TRADE NAME INDEX      GENERIC NAME INDEX      FEEDBACK
Information presented by Malahyde Information Systems © Copyright 1996-2005